| Size & multiples | |||
| Market Cap | $33.85B | Enterprise Value | $42.22B |
| P/E (TTM) | 33.69× | PEG (trailing) | 0.21× |
| P/S | 13.87× | P/FCF | — |
| EV/EBITDA | 26.50× | EV/EBIT | 26.58× |
| EV/Sales | 17.30× | EV/FCF | — |
| FCF Yield | — | Buyback Yield | 1.68% |
| Owner Earnings Yield | — | Shareholder Yield | — |
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.42 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 6.09% |
| After-tax Cost of Debt | 3.75% | Synthetic credit rating | A |
| Cost of Debt · embedded (pre-tax) | 3.75% | Cost of Debt · marginal (synthetic) | 4.78% |
| WACC | 5.60% | ROIC | 8.89% |
| EVA Spread (ROIC−WACC) | 3.29% | EVA | $593.4M |
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM $1.78 · revenue TTM $2.44B · FCF TTM —
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Rich vs Health Care on P/E
P/E 69th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 33.7x | 24.4x | 13.0x–39.3x | 69 ↑rich |
| Net Margin | 32.4% | -21.2% | -325.3%–7.2% | 95 ↑strong |
| Operating Margin | 65.6% | -34.5% | -552.0%–8.0% | 100 ↑strong |
